Cargando…

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

BACKGROUND AND OBJECTIVES: Chronic obstructive pulmonary disease (COPD) affects over 250 million people globally, carrying a notable economic burden. This systematic literature review aimed to highlight the economic burden associated with moderate-to-very severe COPD and to investigate key drivers o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iheanacho, Ike, Zhang, Shiyuan, King, Denise, Rizzo, Maria, Ismaila, Afisi S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049777/ https://www.ncbi.nlm.nih.gov/pubmed/32161455 http://dx.doi.org/10.2147/COPD.S234942

Ejemplares similares

Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review
por: Dang-Tan, Tam, et al.
Publicado: (2015)

Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review
por: Czira, Alexandrosz, et al.
Publicado: (2023)

Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
por: Zhang, Shiyuan, et al.
Publicado: (2020)

Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England
por: Sansbury, Leah B, et al.
Publicado: (2022)

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review
por: Ismaila, Afisi S, et al.
Publicado: (2013)

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada
por: Dang-Tan, Tam, et al.
Publicado: (2017)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
por: Sicras Mainar, Antoni, et al.
Publicado: (2019)

Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
por: Punekar, Yogesh Suresh, et al.
Publicado: (2015)

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
por: Neches García, Victoria, et al.
Publicado: (2022)

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
por: Ismaila, Afisi Segun, et al.
Publicado: (2015)

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
por: Shah, Dhvani, et al.
Publicado: (2018)

Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review
por: Iheanacho, Ike, et al.
Publicado: (2021)

The clinical and economic burden of chronic obstructive pulmonary disease in the USA
por: Guarascio, Anthony J, et al.
Publicado: (2013)

Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice
por: Sansbury, Leah B, et al.
Publicado: (2021)

Models for estimating projections for the prevalence and disease burden of chronic obstructive pulmonary disease (COPD): systematic review protocol
por: McLean, Susannah, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective
por: Schroeder, Melanie, et al.
Publicado: (2020)

Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England
por: Sansbury, Leah B, et al.
Publicado: (2021)

The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoon Duk, et al.
Publicado: (2020)

Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study
por: Paly, Victoria Federico, et al.
Publicado: (2019)

Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers
por: Jansen, Evalyne M., et al.
Publicado: (2021)

The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD)
por: Li, Chin-Ling, et al.
Publicado: (2022)

Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial
por: Ismaila, Afisi S., et al.
Publicado: (2017)

Serum bilirubin and chronic obstructive pulmonary disease (COPD): a systematic review
por: MacDonald, David M., et al.
Publicado: (2021)

Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review
por: Gutiérrez Villegas, Celia, et al.
Publicado: (2021)

Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review
por: Gomez, Nancy, et al.
Publicado: (2022)

Tai Chi for Chronic Obstructive Pulmonary Disease (COPD): An Overview of Systematic Reviews
por: Yang, Luping, et al.
Publicado: (2021)

Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
por: Adeloye, Davies, et al.
Publicado: (2021)

Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD)
por: Peña-Longobardo, Luz María, et al.
Publicado: (2015)

Understanding the economic burden of chronic cough: a systematic literature review
por: Bali, Vishal, et al.
Publicado: (2023)

A Systematic Literature Review of the Humanistic Burden of COPD
por: Hurst, John R, et al.
Publicado: (2021)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
por: Bremner, Peter R., et al.
Publicado: (2018)

An atlas of chronic obstructive pulmonary disease, COPD
por: Hansel, T. T. (Trevor T.), 1956-
Publicado: (2004)

Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study
por: ur Rehman, Anees, et al.
Publicado: (2020)

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany
por: Lewis, Hannah B, et al.
Publicado: (2020)

Economic Burden of COPD in the Presence of Comorbidities
por: Mannino, David M., et al.
Publicado: (2015)

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis
por: Huisman, Eline L, et al.
Publicado: (2015)

Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011)

Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
por: Sansbury, Leah B, et al.
Publicado: (2021)

Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: a systematic review
por: Kelly, Niamh, et al.
Publicado: (2021)

Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review
por: Chow, Ronald, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qk4bft27gs6q2j86i5qfd98knp